HNRNPA2B1 and non-small cell lung carcinoma: Lei et al., (2018) demonstrated that lncRNA H19 is secreted through hnRNPA2B1‐mediated packaging into exosomes, promoting resistance to gefitinib (an EGFR‐tyrosine kinase inhibitor) in NSCLC cells.